LAVA Therapeutics N.V.

NASDAQ: LVTX · Real-Time Price · USD
1.52
-0.02 (-1.30%)
At close: Aug 15, 2025, 3:59 PM
1.52
-0.33%
After-hours: Aug 15, 2025, 04:04 PM EDT

LAVA Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-28.11M -25.18M -27.48M -24.07M -28.38M -41.7M -50.19M -40.36M -35.03M -31.66M -28.86M -39.12M -40.32M -52.65M -45.83M -41.66M -37.66M
Depreciation & Amortization
-236K 467K 1.04M 1.15M 1.21M 1.28M 1.2M 1.05M 926K 781K 884.87K 900.63K 727.85K 639.82K 676.94K 572.31K 628.92K
Stock-Based Compensation
2.67M 3.23M 3.56M 3.77M 4.5M 5.04M 5.02M 4.94M 3.75M 4.36M 5.07M 5.63M 6.47M 4.99M 3.65M 2.33M 1.24M
Other Working Capital
4.31M 3.88M -797.61K -8.66M -10.36M -5.84M 41.09M 28.04M 32.33M 29.01M -14.88M 2.47M 400.16K -1.65M -5.16M -4.72M 5.83M
Other Non-Cash Items
-317K -1.65M 1.09M -1.79M -2.3M -488K 1.93M 766K -2.22M -3.06M -6.13M -3.43M 450.36K 1.17M 522.53K 562.54K 735.48K
Deferred Income Tax
59K -10K -310K -265K -277K -279K -287K -282K -260K -249K -247.22K -250.73K -212.88K -181.84K -168.42K 93.76K 134.63K
Change in Working Capital
4.2M 3.62M -6.22M -5.93M -6.59M -2.83M 49.21M 33.94M 36.41M 34.11M -9.1M 3.16M -3.21M 12.61M 4.65M 6.07M 20M
Operating Cash Flow
-16.39M -19.54M -28.26M -27.08M -31.76M -38.97M 6.88M -9K 3.34M 4.04M -38.62M -33.29M -36.09M -33.42M -36.5M -32.02M -14.92M
Capital Expenditures
-23K -23K -14.24K 2.76K -221.24K -721.24K -995K -964K -764K -587K -530.66K -1.12M -1.03M -893.35K -799.6K -563.66K -666.83K
Cash Acquisitions
-8.2K 80.8K 89K 16.02M 15.61M 15.52M 19.14M -3.49M -6.47M -6.47M -10.09M -3.39M n/a n/a n/a n/a n/a
Purchase of Investments
-77.44M -96.87M -111.53M -121.34M -114.45M -90.08M -78.22M -56.82M -53.64M -70.88M -50.17M -42.23M -20.86M -3.62M n/a n/a n/a
Sales Maturities Of Investments
104.38M 109.27M 104.27M 96.77M 90M 73.18M 66.13M 68.13M 68.05M 80.81M 60.35M 45.86M 20.93M n/a n/a n/a n/a
Other Investing Acitivies
2.86K 91.86K 89.1K -15.84M -15.44M -7.99M -11.6M 11.02M 14.01M 6.47M 12.93M -42.62M -46M -46M -48.85M 12.19K 1.3K
Investing Cash Flow
26.92M 12.47M -7.18M -24.48M -24.59M -17.64M -13.09M 10.35M 13.65M 9.35M 12.5M -43.51M -46.96M -50.52M -49.65M -551.47K -665.54K
Debt Repayment
-588K -596K -269.8K -36.8K -181.8K -270.8K -407K -277K -99K 268K -262.17K -39.17K 141.83K -44.17K 1.02M 1.38M 1.63M
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 161.12K 161.12K 161.12K -118.5K -5.9M -5.9M
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -1.92M -73.41M -73.41M -73.41M -71.49M
Other Financial Acitivies
-174.66K -166.66K -273.2K -275.2K -292.2K -300.2K n/a n/a 15K 15K 15K -4.08M -2.32M -2.32M -2.32M 4.91M 3.19M
Financial Cash Flow
-569K -569K -543K -312K -474K -571K -407K -277K -84K 283K 1.81M -2.06M 5.32M 177.85M 177.42M 202.42M 195.51M
Net Cash Flow
-3.51M -9.22M -35.7M -52.52M -57.42M -56.1M -1.67M 11.74M 14.88M 9.46M -37.3M -86.56M -82.9M 90.28M 92.09M 169.05M 180.12M
Free Cash Flow
-16.42M -19.57M -28.27M -27.08M -31.98M -39.69M 5.89M -973K 2.57M 3.46M -39.15M -34.42M -37.11M -34.32M -37.3M -32.59M -15.59M